Your browser doesn't support javascript.
loading
Moderators of exercise effects on self-reported cognitive functioning in cancer survivors: an individual participant data meta-analysis.
Hiensch, Anouk E; Beckhaus, Julia; Witlox, Lenja; Monninkhof, Evelyn M; Schagen, Sanne B; van Vulpen, Jonna K; Sweegers, Maike G; Newton, Robert U; Aaronson, Neil K; Galvão, Daniel A; Steindorf, Karen; Stuiver, Martijn M; Mesters, Ilse; Knoop, Hans; Goedendorp, Martine M; Bohus, Martin; Thorsen, Lene; Schulz, Karl-Heinz; Schmidt, Martina E; Ulrich, Cornelia M; Sonke, Gabe S; van Harten, Wim H; Winters-Stone, Kerri M; Velthuis, Miranda J; Taaffe, Dennis R; van Mechelen, Willem; Kersten, Marie José; Nollet, Frans; Wiskemann, Joachim; Buffart, Laurien M; May, Anne M.
Affiliation
  • Hiensch AE; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Beckhaus J; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Witlox L; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Monninkhof EM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Schagen SB; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Vulpen JK; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Sweegers MG; Division of Psychosocial Research and Epidemiology & Center for Quality of Life, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Newton RU; Exercise Medicine Research Institute, Edith Cowan University, Perth, WA, Australia.
  • Aaronson NK; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Galvão DA; Exercise Medicine Research Institute, Edith Cowan University, Perth, WA, Australia.
  • Steindorf K; Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
  • Stuiver MM; Division of Psychosocial Research and Epidemiology & Center for Quality of Life, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Mesters I; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands.
  • Knoop H; Department of Medical Psychology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
  • Goedendorp MM; Department of Health Psychology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Bohus M; Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
  • Thorsen L; Institute of Psychiatric and Psychosomatic Psychotherapy, Central Institute of Mental Health, Mannheim, Heidelberg University, Heidelberg, Germany.
  • Schulz KH; Faculty of Health, University of Antwerp, Antwerp, Belgium.
  • Schmidt ME; National Advisory Unit on Late Effects after Cancer, Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Ulrich CM; Department of Clinical Service, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
  • Sonke GS; Athleticum - Competence Center for Sports- and Exercise Medicine and Institute for Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • van Harten WH; Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
  • Winters-Stone KM; Huntsman Cancer Institute and Department of Population Health Sciences, University of Utah, Salt Lake City, USA.
  • Velthuis MJ; Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Taaffe DR; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Mechelen W; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands.
  • Kersten MJ; Division of Oncological Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Nollet F; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
  • Wiskemann J; Exercise Medicine Research Institute, Edith Cowan University, Perth, WA, Australia.
  • Buffart LM; Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam UMC, location: Vrije Universiteit, Amsterdam, The Netherlands.
  • May AM; School of Human Movement and Nutrition Sciences, Faculty of Health and Behavioural Sciences, University of Queensland, Brisbane, Australia.
J Cancer Surviv ; 2023 May 09.
Article in En | MEDLINE | ID: mdl-37160571
ABSTRACT

PURPOSE:

This individual participant data meta-analysis (IPD-MA) assesses exercise effects on self-reported cognitive functioning (CF) and investigates whether effects differ by patient-, intervention-, and exercise-related characteristics.

METHODS:

IPD from 16 exercise RCTs, including 1987 patients across multiple types of non-metastatic cancer, was pooled. A one-stage IPD-MA using linear mixed-effect models was performed to assess exercise effects on self-reported CF (z-score) and to identify whether the effect was moderated by sociodemographic, clinical, intervention- and exercise-related characteristics, or fatigue, depression, anxiety, and self-reported CF levels at start of the intervention (i.e., baseline). Models were adjusted for baseline CF and included a random intercept at study level to account for clustering of patients within studies. A sensitivity analysis was performed in patients who reported cognitive problems at baseline.

RESULTS:

Minimal significant beneficial exercise effects on self-reported CF (ß=-0.09 [-0.16; -0.02]) were observed, with slightly larger effects when the intervention was delivered post-treatment (n=745, ß=-0.13 [-0.24; -0.02]), and no significant effect during cancer treatment (n=1,162, ß=-0.08 [-0.18; 0.02]). Larger effects were observed in interventions of 12 weeks or shorter (ß=-0.14 [-0.25; -0.04]) or 24 weeks or longer (ß=-0.18 [-0.32; -0.02]), whereas no effects were observed in interventions of 12-24 weeks (ß=0.01 [-0.13; 0.15]). Exercise interventions were most beneficial when provided to patients without anxiety symptoms (ß=-0.10 [-0.19; -0.02]) or after completion of treatment in patients with cognitive problems (ß=-0.19 [-0.31; -0.06]). No other significant moderators were identified.

CONCLUSIONS:

This cross-cancer IPD meta-analysis observed small beneficial exercise effects on self-reported CF when the intervention was delivered post-treatment, especially in patients who reported cognitive problems at baseline. IMPLICATIONS FOR CANCER SURVIVORS This study provides some evidence to support the prescription of exercise to improve cognitive functioning. Sufficiently powered trials are warranted to make more definitive recommendations and include these in the exercise guidelines for cancer survivors.
Key words

Full text: 1 Database: MEDLINE Type of study: Guideline / Prognostic_studies / Systematic_reviews Language: En Journal: J Cancer Surviv Year: 2023 Type: Article Affiliation country: Netherlands

Full text: 1 Database: MEDLINE Type of study: Guideline / Prognostic_studies / Systematic_reviews Language: En Journal: J Cancer Surviv Year: 2023 Type: Article Affiliation country: Netherlands